Incidence of sodium–glucose cotransporter-2 inhibitor-associated perioperative ketoacidosis in surgical patients: a prospective cohort study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Incidence of sodium–glucose cotransporter-2 inhibitor-associated perioperative ketoacidosis in surgical patients: a prospective cohort study ; day:17 ; month:3 ; year:2024 ; pages:1-11
Journal of anesthesia ; (17.3.2024), 1-11
- Creator
-
Seki, Hiroyuki
Kuratani, Norifumi
Shiga, Toshiya
Iwasaki, Yudai
Karita, Kanae
Yasuda, Kazuki
Yamamoto, Natsuko
Nakanishi, Yuko
Shigematsu, Kenji
Kobayashi, Kensuke
Saito, Junichi
Kondo, Ichiro
Yaida, Nozomu
Watanabe, Hidenobu
Higashi, Midoriko
Shirasaka, Tetsuro
Doshu-Kajiura, Akira
Edanaga, Mitsutaka
Tanaka, Satoshi
Ikumi, Saori
Ito, Shingo
Okada, Masayuki
Yorozu, Tomoko
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00540-024-03335-3
- URN
-
urn:nbn:de:101:1-2405210714442.101969785398
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Seki, Hiroyuki
- Kuratani, Norifumi
- Shiga, Toshiya
- Iwasaki, Yudai
- Karita, Kanae
- Yasuda, Kazuki
- Yamamoto, Natsuko
- Nakanishi, Yuko
- Shigematsu, Kenji
- Kobayashi, Kensuke
- Saito, Junichi
- Kondo, Ichiro
- Yaida, Nozomu
- Watanabe, Hidenobu
- Higashi, Midoriko
- Shirasaka, Tetsuro
- Doshu-Kajiura, Akira
- Edanaga, Mitsutaka
- Tanaka, Satoshi
- Ikumi, Saori
- Ito, Shingo
- Okada, Masayuki
- Yorozu, Tomoko
- SpringerLink (Online service)
Other Objects (12)
Sodium-glucose cotransporter 2 inhibitor-associated perioperative ketoacidosis: a systematic review of case reports
Sodium–glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy
Sodium-Glucose Co-Transporter 2 Inhibitors and Fracture Risk
Euglycemic diabetic ketoacidosis associated with sodium-glucose cotransporter-2 inhibitor use: a case report and review of the literature
Sodium–glucose cotransporter 2 inhibitor-induced euglycemic diabetic ketoacidosis in a patient with coronavirus disease 2019: a case report
Euglycemic diabetic ketoacidosis induced by sodium-glucose cotransporter 2 inhibitor in the setting of prolonged fasting: a case report
Sodium-Glucose Cotransporter-2 Inhibition and the Glomerulus: A Review
Sodium-glucose co-transporter 2 inhibitor-induced euglycemic diabetic ketoacidosis in a Type 2 diabetes patient not absolutely insulin-deficient!
Hepatic benefits of sodium-glucose cotransporter 2 inhibitors in liver disorders
Sodium-glucose cotransporter 2 inhibition prevents renal fibrosis in cyclosporine nephropathy
Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors and Cardiovascular Disease: A Systematic Review
Sodium-glucose cotransporter 2 inhibitors and mitochondrial functions : state of the art
Sodium-glucose cotransporter 2 inhibitor-associated perioperative ketoacidosis: a systematic review of case reports
Sodium–glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy
Sodium-Glucose Co-Transporter 2 Inhibitors and Fracture Risk
Euglycemic diabetic ketoacidosis associated with sodium-glucose cotransporter-2 inhibitor use: a case report and review of the literature
Sodium–glucose cotransporter 2 inhibitor-induced euglycemic diabetic ketoacidosis in a patient with coronavirus disease 2019: a case report
Euglycemic diabetic ketoacidosis induced by sodium-glucose cotransporter 2 inhibitor in the setting of prolonged fasting: a case report
Sodium-Glucose Cotransporter-2 Inhibition and the Glomerulus: A Review
Sodium-glucose co-transporter 2 inhibitor-induced euglycemic diabetic ketoacidosis in a Type 2 diabetes patient not absolutely insulin-deficient!
Hepatic benefits of sodium-glucose cotransporter 2 inhibitors in liver disorders
Sodium-glucose cotransporter 2 inhibition prevents renal fibrosis in cyclosporine nephropathy
Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors and Cardiovascular Disease: A Systematic Review
Sodium-glucose cotransporter 2 inhibitors and mitochondrial functions : state of the art
Sodium-glucose cotransporter 2 inhibitor-associated perioperative ketoacidosis: a systematic review of case reports
Sodium–glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy
Sodium-Glucose Co-Transporter 2 Inhibitors and Fracture Risk
Euglycemic diabetic ketoacidosis associated with sodium-glucose cotransporter-2 inhibitor use: a case report and review of the literature
Sodium–glucose cotransporter 2 inhibitor-induced euglycemic diabetic ketoacidosis in a patient with coronavirus disease 2019: a case report
Euglycemic diabetic ketoacidosis induced by sodium-glucose cotransporter 2 inhibitor in the setting of prolonged fasting: a case report
Sodium-Glucose Cotransporter-2 Inhibition and the Glomerulus: A Review
Sodium-glucose co-transporter 2 inhibitor-induced euglycemic diabetic ketoacidosis in a Type 2 diabetes patient not absolutely insulin-deficient!
Hepatic benefits of sodium-glucose cotransporter 2 inhibitors in liver disorders
Sodium-glucose cotransporter 2 inhibition prevents renal fibrosis in cyclosporine nephropathy
Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors and Cardiovascular Disease: A Systematic Review